IARC Monographs evaluation of the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus

The International Agency for Research on Cancer (IARC)  has evaluated the carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. The outcome of the assessment has been published in a summary article in The Lancet Oncology and will be described in detail in Volume 137 of the IARC Monographs, to be published in 2025.